
Octopus Ventures in £1.5m round for Metrasens
Octopus Ventures has invested £1.5m in technology business Metrasens.
Metrasens is a business that specialises in metal detection products for the healthcare and security markets. The new funds will be used to further develop its Ferroguard MRI detection system, which is being used to reduce the likelihood of injuries caused by projectiles in MRI units in both the US and Europe.
The funds were provided by the Octopus Titan VCT 1, Titan VCT 2 and Titan VCT 3 Funds together with the Octopus Eureka EIS Portfolio Service and the Octopus Investor Group.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater